Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Acura Pharmaceuticals, Inc (ACUR) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Acura Pharmaceuticals, Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 786947.
Total stock buying since 2014: $193,667.
Total stock sales since 2014: $439,174.
Total stock option exercises since 2014: $10,126.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 0 | $0 | 0 | $0 | 150,000 | $0 |
| 2025 | 0 | $0 | 0 | $0 | 150,000 | $0 |
| 2024 | 0 | $0 | 0 | $0 | 187,500 | $0 |
| 2023 | 0 | $0 | 0 | $0 | 718,664 | $0 |
| 2022 | 0 | $0 | 0 | $0 | 447,662 | $0 |
| 2021 | 0 | $0 | 0 | $0 | 484,829 | $9,060 |
| 2020 | 0 | $0 | 0 | $0 | 341,668 | $0 |
| 2019 | 0 | $0 | 0 | $0 | 266,664 | $0 |
| 2018 | 0 | $0 | 0 | $0 | 237,534 | $0 |
| 2017 | 1,896,534 | $193,667 | 2,195,734 | $219,573 | 103,223 | $1,066 |
| 2016 | 0 | $0 | 0 | $0 | 32,815 | $0 |
| 2015 | 0 | $0 | 275,823 | $219,601 | 77,206 | $0 |
| 2014 | 0 | $0 | 0 | $0 | 22,059 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-01 | 0 | $0 | 0 | $0 | 150,000 | $0 |
| 2025-01 | 0 | $0 | 0 | $0 | 150,000 | $0 |
| 2024-01 | 0 | $0 | 0 | $0 | 187,500 | $0 |
| 2023-11 | 0 | $0 | 0 | $0 | 160,000 | $0 |
| 2023-01 | 0 | $0 | 0 | $0 | 558,664 | $0 |
| 2022-08 | 0 | $0 | 0 | $0 | 180,998 | $0 |
| 2022-01 | 0 | $0 | 0 | $0 | 266,664 | $0 |
| 2021-02 | 0 | $0 | 0 | $0 | 60,000 | $9,060 |
| 2021-01 | 0 | $0 | 0 | $0 | 424,829 | $0 |
| 2020-01 | 0 | $0 | 0 | $0 | 341,668 | $0 |
| 2019-01 | 0 | $0 | 0 | $0 | 266,664 | $0 |
| 2018-01 | 0 | $0 | 0 | $0 | 237,534 | $0 |
| 2017-12 | 1,885,734 | $188,573 | 2,195,734 | $219,573 | 0 | $0 |
| 2017-08 | 10,800 | $5,094 | 0 | $0 | 0 | $0 |
| 2017-02 | 0 | $0 | 0 | $0 | 1,166 | $1,066 |
| 2017-01 | 0 | $0 | 0 | $0 | 102,057 | $0 |
| 2016-01 | 0 | $0 | 0 | $0 | 32,815 | $0 |
| 2015-06 | 0 | $0 | 104,823 | $113,495 | 0 | $0 |
| 2015-01 | 0 | $0 | 171,000 | $106,106 | 77,206 | $0 |
| 2014-01 | 0 | $0 | 0 | $0 | 22,059 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-01-02 | Thangaraj Immanuel | Option Ex | 50,000 | .00 | 0 |
| 2026-01-02 | Ross George K | Option Ex | 50,000 | .00 | 0 |
| 2026-01-02 | Skelly William G | Option Ex | 50,000 | .00 | 0 |
| 2025-01-02 | Thangaraj Immanuel | Option Ex | 50,000 | .00 | 0 |
| 2025-01-02 | Ross George K | Option Ex | 50,000 | .00 | 0 |
| 2025-01-02 | Skelly William G | Option Ex | 50,000 | .00 | 0 |
| 2024-01-02 | Thangaraj Immanuel | Option Ex | 50,000 | .00 | 0 |
| 2024-01-02 | Ross George K | Option Ex | 50,000 | .00 | 0 |
| 2024-01-02 | Skelly William G | Option Ex | 50,000 | .00 | 0 |
| 2024-01-02 | Wesson Bruce F | Option Ex | 37,500 | .00 | 0 |
| 2023-11-20 | Brzeczko Albert W (See Remarks) | Option Ex | 40,000 | .00 | 0 |
| 2023-11-20 | Jones Robert B (President & CEO) | Option Ex | 40,000 | .00 | 0 |
| 2023-11-20 | Seiser Robert A (VP, Treasurer & Controller) | Option Ex | 40,000 | .00 | 0 |
| 2023-11-20 | Clemens Peter A (Senior VP & CFO) | Option Ex | 40,000 | .00 | 0 |
| 2023-01-03 | Brzeczko Albert W (See Remark) | Option Ex | 68,000 | .00 | 0 |
| 2023-01-03 | Jones Robert B (President & CEO) | Option Ex | 50,000 | .00 | 0 |
| 2023-01-03 | Seiser Robert A (VP, Treasurer & Controller) | Option Ex | 20,000 | .00 | 0 |
| 2023-01-03 | Thangaraj Immanuel | Option Ex | 66,666 | .00 | 0 |
| 2023-01-03 | Ross George K | Option Ex | 66,666 | .00 | 0 |
| 2023-01-03 | Skelly William G | Option Ex | 66,666 | .00 | 0 |
| 2023-01-03 | Wesson Bruce F | Option Ex | 66,666 | .00 | 0 |
| 2023-01-03 | Clemens Peter A (Senior VP & CFO) | Option Ex | 80,000 | .00 | 0 |
| 2022-08-03 | Brzeczko Albert W (VP, Pharma Sciences - APT) | Option Ex | 43,333 | .00 | 0 |
| 2022-08-03 | Jones Robert B (President & CEO) | Option Ex | 63,666 | .00 | 0 |
| 2022-08-03 | Seiser Robert A (VP, Controller & Treasurer) | Option Ex | 24,666 | .00 | 0 |
| 2022-08-03 | Clemens Peter A (Senior VP & CFO) | Option Ex | 49,333 | .00 | 0 |
| 2022-01-03 | Thangaraj Immanuel | Option Ex | 66,666 | .00 | 0 |
| 2022-01-03 | Ross George K | Option Ex | 66,666 | .00 | 0 |
| 2022-01-03 | Skelly William G | Option Ex | 66,666 | .00 | 0 |
| 2022-01-03 | Wesson Bruce F | Option Ex | 66,666 | .00 | 0 |
| 2021-02-24 | Emigh James F (VP, Corporate Development) | Option Ex | 20,000 | .15 | 3,020 |
| 2021-02-24 | Clemens Peter A (Senior VP & CFO) | Option Ex | 40,000 | .15 | 6,040 |
| 2021-01-04 | Brzeczko Albert W (VP, Pharmaceutical Sciences) | Option Ex | 43,334 | .00 | 0 |
| 2021-01-04 | Jones Robert B (President & CEO) | Option Ex | 63,667 | .00 | 0 |
| 2021-01-04 | Seiser Robert A (VP, Treasurer & Controller) | Option Ex | 24,667 | .00 | 0 |
| 2021-01-04 | Thangaraj Immanuel | Option Ex | 54,790 | .00 | 0 |
| 2021-01-04 | Emigh James F (VP, Corporate Development) | Option Ex | 24,667 | .00 | 0 |
| 2021-01-04 | Ross George K | Option Ex | 54,790 | .00 | 0 |
| 2021-01-04 | Skelly William G | Option Ex | 54,790 | .00 | 0 |
| 2021-01-04 | Wesson Bruce F | Option Ex | 54,790 | .00 | 0 |
| 2021-01-04 | Clemens Peter A (Senior VP & CFO) | Option Ex | 49,334 | .00 | 0 |
| 2020-01-02 | Brzeczko Albert W (VP Pharmaceutical Sciences APT) | Option Ex | 9,334 | .00 | 0 |
| 2020-01-02 | Jones Robert B (President & CEO) | Option Ex | 13,667 | .00 | 0 |
| 2020-01-02 | Seiser Robert A (VP, Treasurer & Controller) | Option Ex | 4,667 | .00 | 0 |
| 2020-01-02 | Thangaraj Immanuel | Option Ex | 83,333 | .00 | 0 |
| 2020-01-02 | Emigh James F (VP, Corporate Development) | Option Ex | 4,667 | .00 | 0 |
| 2020-01-02 | Ross George K | Option Ex | 50,000 | .00 | 0 |
| 2020-01-02 | Skelly William G | Option Ex | 83,333 | .00 | 0 |
| 2020-01-02 | Wesson Bruce F | Option Ex | 83,333 | .00 | 0 |
| 2020-01-02 | Clemens Peter A (Senior VP & CFO) | Option Ex | 9,334 | .00 | 0 |
| 2019-01-02 | Thangaraj Immanuel | Option Ex | 66,666 | .00 | 0 |
| 2019-01-02 | Ross George K | Option Ex | 66,666 | .00 | 0 |
| 2019-01-02 | Skelly William G | Option Ex | 66,666 | .00 | 0 |
| 2019-01-02 | Wesson Bruce F | Option Ex | 66,666 | .00 | 0 |
| 2018-01-02 | Thangaraj Immanuel (Director) | Option Ex | 35,714 | .00 | 0 |
| 2018-01-02 | Ross George K (Director) | Option Ex | 82,774 | .00 | 0 |
| 2018-01-02 | Skelly William G (Director) | Option Ex | 59,523 | .00 | 0 |
| 2018-01-02 | Wesson Bruce F (Director) | Option Ex | 59,523 | .00 | 0 |
| 2017-12-14 | Brzeczko Albert W (VP Technical Affairs - APT) | Buy | 300,000 | .10 | 30,000 |
| 2017-12-14 | Jones Robert B (President and CEO) | Buy | 400,000 | .10 | 40,000 |
| 2017-12-14 | Seiser Robert A (VP, Controller & Treasurer) | Buy | 300,000 | .10 | 30,000 |
| 2017-12-14 | Emigh James F (VP Corporate Development) | Buy | 400,000 | .10 | 40,000 |
| 2017-12-14 | Ross George K (Director) | Buy | 50,000 | .10 | 5,000 |
| 2017-12-14 | Skelly William G (Director) | Buy | 100,000 | .10 | 10,000 |
| 2017-12-14 | Wesson Bruce F (Director) | Buy | 335,734 | .10 | 33,573 |
| 2017-12-14 | Galen Partners Iii L P (Other) | Sale | 2,195,734 | .10 | 219,573 |
| 2017-08-29 | Brzeczko Albert W (VP Technical Affairs - APT) | Buy | 4,000 | .47 | 1,880 |
| 2017-08-28 | Brzeczko Albert W (VP Technical Affairs - APT) | Buy | 2,000 | .46 | 910 |
| 2017-08-25 | Brzeczko Albert W (VP Technical Affairs - APT) | Buy | 4,800 | .48 | 2,304 |
| 2017-02-07 | Seiser Robert A (VP, Controller & Treasurer) | Option Ex | 1,166 | .92 | 1,066 |
| 2017-01-03 | Thangaraj Immanuel (Director) | Option Ex | 26,432 | .00 | 0 |
| 2017-01-03 | Ross George K (Director) | Option Ex | 735 | .00 | 0 |
| 2017-01-03 | Skelly William G (Director) | Option Ex | 26,432 | .00 | 0 |
| 2017-01-03 | Wesson Bruce F (Director) | Option Ex | 22,026 | .00 | 0 |
| 2016-01-04 | Thangaraj Immanuel (Director) | Option Ex | 6,185 | .00 | 0 |
| 2016-01-04 | Ross George K (Director) | Option Ex | 8,074 | .00 | 0 |
| 2016-01-04 | Skelly William G (Director) | Option Ex | 8,247 | .00 | 0 |
| 2016-01-04 | Wesson Bruce F (Director) | Option Ex | 10,309 | .00 | 0 |
| 2015-06-17 | Galen Partners Iii L P (10% Owner) | Sale | 3,900 | 1.05 | 4,095 |
| 2015-06-16 | Galen Partners Iii L P (10% Owner) | Sale | 100,923 | 1.08 | 109,400 |
| 2015-01-12 | Galen Partners Iii L P (10% Owner) | Sale | 35,000 | .64 | 22,470 |
| 2015-01-09 | Galen Partners Iii L P (10% Owner) | Sale | 36,000 | .65 | 23,436 |
| 2015-01-08 | Galen Partners Iii L P (10% Owner) | Sale | 100,000 | .60 | 60,200 |
| 2015-01-02 | Ross George K (Director) | Option Ex | 11,030 | .00 | 0 |
| 2015-01-02 | Skelly William G (Director) | Option Ex | 29,412 | .00 | 0 |
| 2015-01-02 | Wesson Bruce F (Director) | Option Ex | 36,764 | .00 | 0 |
| 2014-01-02 | Thangaraj Immanuel (Director) | Option Ex | 22,059 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of ACUR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Acura Pharmaceuticals, Inc (symbol ACUR, CIK number 786947) see the Securities and Exchange Commission (SEC) website.